SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending due to anticipation surrounding its earnings report, with the community actively discussing revenue expectations, EPS, and guidance updates. Community members are debating whether the stock will experience a post-earnings surge or a "sell the news" pullback, a pattern observed in previous earnings cycles. The broader context includes potential tailwinds from expected rate cuts and the possibility of S&P 500 inclusion.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending following reports of a new partnership with OpenAI, integrating the payment platform into ChatGPT and potentially opening up AI-driven commerce to millions of users. Community members are discussing the potential for this deal to revitalize growth and boost the stock price, alongside positive earnings and the initiation of a dividend.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors discuss its upcoming earnings report and potential impact on the healthcare sector. Community members are weighing in on whether the company can maintain its guidance amid industry-wide cost pressures, and some anticipate a positive reaction based on Warren Buffett's investment and potential for a strong outlook. Traders are also closely watching for news related to ACA subsidies and the DOJ case, which could act as catalysts.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors digest recent earnings and guidance, with community sentiment split between those seeing a buying opportunity and those anticipating further declines. Discussions revolve around the company's cost-cutting measures, Q4 revenue outlook, and the sustainability of its dividend yield. The broader context includes concerns about demand, labor costs, and competition in the logistics sector.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco ($CCJ) is trending as a new US Government nuclear power pact has sparked significant interest and bullish sentiment, especially with the construction of new nuclear reactors on the horizon. Community discussions revolve around the stock's breakout potential, fueled by growing demand for nuclear energy and positive Elliott Wave technical analysis. With increasing global support for nuclear power, $CCJ is seen as a key player in the expanding uranium market, although some caution is advised due to its high PE ratio.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as the community discusses the potential impact of a newly listed Hedera ETF, alongside existing positive sentiment toward enterprise use cases. Some believe this ETF could mirror previous rallies seen with other cryptocurrencies upon ETF approvals, while others caution about potential short-term corrections. Bullish community members are speculating on price targets and institutional adoption, emphasizing Hedera's underlying technology.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending following news of its acquisition of Arduino, signaling a strategic push into robotics and AI, with the community actively discussing the implications for the company's diversification beyond mobile chips. Investors are evaluating whether this move will position QCOM to better compete in the expanding AI and IoT sectors. Some analysts view this acquisition as a potential catalyst, while others express skepticism.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as community members discuss recent Incyte earnings highlighting strong sales of Niktimvo, a drug Syndax brought to market, leading to speculation about a potential buyout. Bullish sentiment is fueled by the drug's successful launch and future potential, with some analysts setting high price targets. The community is actively debating the impact of recent FDA approval and upcoming quarterly financials, while also comparing Syndax to competitors.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display Technologies, Specialty Materials, Environmental Technologies, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computer, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Environmental Technologies segment focuses on manufacturing ceramic substrates and filter products for emissions control in mobile applications. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning ($GLW) is trending due to strong Q3 results, exceeding expectations for EPS and revenue, alongside positive guidance for Q4. Community members are highlighting the company's growth in Optical Communications, driven by AI and a recent partnership with Apple. Analysts are also raising price targets, reinforcing positive sentiment around Corning's potential in AI and optical solutions.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

ALDX is trending as investors discuss the recent positive Phase 2 clinical trial results for ADX-629 and the company's focus on next-generation molecules. The community is weighing the potential for a run-up ahead of the December PDUFA date for reproxalap and speculating about a possible acquisition by AbbVie. Positive sentiment is building based on the company's pipeline and upcoming catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jefferies🏁 $JBIO Buy-$16 
$VRTX $OTSKF  
Jefferies said in its initiation report: 
&quot;We like $JBIO&#39;s long-acting anti-APRIL (JADE101) in IgAN: 
1) our PK work suggests &#39;101 can achieve Q8/12W dosing, 
2) we think efficacy will be as good as povetacicept w/ pot&#39;l upside on % clinical remission, 
3) we expect tolerable safety profile w/o increased serious infections, 
4) we see oppty for disease modifying tx w/ longer dosing interval in IgAN. 
 
We model $915M risk-adj. PS for &#39;101 (POS 30%). Co also has $255M cash/cash eq. w/ runway to &#39;27.&quot;

D. Milne

StockTwits Web

Jade Biosciences Inc

Vertex Pharmaceuticals, Inc.

 $OTSKF  
Jefferies said in its initiation report: 
"We like 

's long-acting anti-APRIL (JADE101) in IgAN: 
1) our PK work suggests '101 can achieve Q8/12W dosing, 
2) we think efficacy will be as good as povetacicept w/ pot'l upside on % clinical remission, 
3) we expect tolerable safety profile w/o increased serious infections, 
4) we see oppty for disease modifying tx w/ longer dosing interval in IgAN. 
 
We model $915M risk-adj. PS for '101 (POS 30%). Co also has $255M cash/cash eq. w/ runway to '27."